Paper
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Published Dec 1, 2004 · Alessandro Cecchi, J. Winum, A. Innocenti
Bioorganic & medicinal chemistry letters
Q2 SJR score
40
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
Sulfonamides derived from 4-isothiocyanato-benzolamide show excellent inhibitory properties against human carbonic anhydrase I, II, and IX, making them potential candidates for developing novel therapies targeting hypoxic tumors.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
The crystal structure of a topically acting antiglaucoma sulfonamide reveals its high affinity for human carbonic anhydrase II, potentially enabling further optimization of inhibitors for glaucoma treatment.
2004·41citations·F. Abbate et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Modulation of carbonic anhydrase activity and its applications in therapy
Modulation of carbonic anhydrase activity through inhibitors or activators leads to various therapeutic applications, including glaucoma treatment, antiepileptics, and cognitive disorders.
2004·145citations·A. Scozzafava et al.·Expert Opinion on Therapeutic Patents
Expert Opinion on Therapeutic Patents
Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.
These new sulfonamide derivatives show high affinity for the tumor-associated isozyme CA IX and their membrane impermeability make them potential candidates for selective inhibition of this enzyme without affecting cytosolic isozymes.
2004·141citations·J. Casey et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
COX-2 selective NSAIDs show unexpected nanomolar affinity for carbonic anhydrase, suggesting potential for glaucoma and anticancer treatment due to related binding site recognition.
2004·413citations·Alexander Weber et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
E7070, a sulfonamide anticancer drug candidate, acts as a potent carbonic anhydrase inhibitor, with potential for use in cancer treatment.
2004·255citations·F. Abbate et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Review Article
Carbonic anhydrase inhibitors show potential as antiglaucoma drugs and can inhibit tumor cell growth, offering potential for developing novel antitumor therapies.
2004·577citations·S. Pastoreková et al.·Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Cancer-associated Isozyme IX with Anions
Anions can inhibit both cytosolic and tumor-associated carbonic anhydrase, with Isozyme IX showing a different inhibition profile than CA I and CA II, potentially impacting physiological processes.
2003·55citations·D. Vullo et al.·Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.
New topical antiglaucoma sulfonamides with esters or amides show better efficacy and longer duration of action than standard drugs dorzolamide and brinzolamide.
2003·29citations·A. Casini et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Citations
Challenging breast cancer through novel sulfonamide-pyridine hybrids: design, synthesis, carbonic anhydrase IX inhibition and induction of apoptosis.
Novel sulfonamide-pyridine hybrids show potential in targeting breast cancer by inducing apoptosis, cell cycle arrest, autophagy, and delaying wound healing.
2023·5citations·N. Zaher et al.·Future medicinal chemistry
Future medicinal chemistry
Protein-Small Molecule Interactions in Native Mass Spectrometry.
Native mass spectrometry provides unprecedented speed and sensitivity in studying protein-small molecule interactions, advancing drug discovery and providing unique insights into polydisperse biomolecular systems.
2021·68citations·Jack L Bennett et al.·Chemical reviews
Chemical reviews
Modulating the Efficacy of Carbonic Anhydrase Inhibitors through Fluorine Substitution.
Inserting fluorine atom(s) within carbonic anhydrase inhibitors can enhance or disrupt ligand protein interactions, depending on the location of the fluorine substitution on the ligand.
2021·25citations·Emanuela Berrino et al.·Angewandte Chemie
Angewandte Chemie
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs.
This review summarizes the mechanism of action of antimycobacterial drugs and resistance mechanisms in Mycobacterium tuberculosis, highlighting the need for novel antimycobacterial drugs for effective tuberculosis therapy.
2021·38citations·Aditi Chauhan et al.·Life sciences
Life sciences
Sulfonamides: Synthesis and the recent applications in Medicinal Chemistry
Sulfonamides have diverse pharmacological effects, including oral diuretics, anticancer agents, and antibacterials, with recent launches including apricoxib and pazopanib.
2020·19citations·M. El-Qaliei et al.·The Egyptian Journal of Chemistry
The Egyptian Journal of Chemistry
Antioxidant and Antibacterial activity of some 2-amino-1,3,4-thiadiazole Schiff’s bases
The 2-amino-1,3,4-thiadiazole Schiff's bases show antibacterial and antioxidant activity against various bacteria and ions, offering potential for pharmaceutical applications.
2019·4citations·Dheyaa H. Ibrahim et al.·Journal of Physics: Conference Series
Journal of Physics: Conference Series
Nanoscale Ion Emitters in Native Mass Spectrometry for Measuring Ligand–Protein Binding Affinities
Nanoscale ion emitters in electrospray ionization mass spectrometry can accurately measure ligand-protein binding constants in solutions with high concentrations of nonvolatile buffers and salts.
2019·86citations·Giang T. H. Nguyen et al.·ACS Central Science
ACS Central Science
Synthesis and biological evaluation of novel N,N'-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors.
Novel N,N'-diaryl cyanoguanidines show potent and selective inhibition of carbonic anhydrase II, an important drug target for antiglaucoma agents.
2018·37citations·Suleyman Akocak et al.·Bioorganic chemistry
Bioorganic chemistry
Effect of mutation in active site residue Trp209 to Val, Leu, Ile and Pro on the catalytic activity and affinity for some benzenesulfonamides of human carbonic anhydrase II
Trp 209 in human carbonic anhydrase II plays a crucial role in catalysis and protein folding, and valine residues are compatible with the hydrophobic region in the active cavity.
2017·1citation·Deryanur Kılıç et al.·Turkish Journal of Biology
Turkish Journal of Biology